US drugs firm Mylan completes $1.75 bln India buyout
US generic drug specialist Mylan said Thursday it had completed its $1.75 billion acquisition of a unit of India's Strides Arcolab, boosting its presence in the high-growth injectable drugs market.
Dec 5, 2013
0
0